Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Chronic Renal Failure

  Free Subscription


Articles published in PLoS Med

Retrieve available abstracts of 16 articles:
HTML format



Single Articles


    February 2021
  1. KU E, Hsu RK, Johansen KL, McCulloch CE, et al
    Recovery of kidney function after dialysis initiation in children and adults in the US: A retrospective study of United States Renal Data System data.
    PLoS Med. 2021;18:e1003546.
    PubMed     Abstract available


    December 2020
  2. SCHRAUBEN SJ, Chen HY, Lin E, Jepson C, et al
    Hospitalizations among adults with chronic kidney disease in the United States: A cohort study.
    PLoS Med. 2020;17:e1003470.
    PubMed     Abstract available


    October 2020
  3. JACOBSON MH, Wu Y, Liu M, Attina TM, et al
    Serially assessed bisphenol A and phthalate exposure and association with kidney function in children with chronic kidney disease in the US and Canada: A longitudinal cohort study.
    PLoS Med. 2020;17:e1003384.
    PubMed     Abstract available


    August 2020
  4. BARRETT PM, McCarthy FP, Evans M, Kublickas M, et al
    Hypertensive disorders of pregnancy and the risk of chronic kidney disease: A Swedish registry-based cohort study.
    PLoS Med. 2020;17:e1003255.
    PubMed     Abstract available


    July 2020
  5. SHARDLOW A, McIntyre NJ, Kolhe NV, Nellums LB, et al
    The association of skin autofluorescence with cardiovascular events and all-cause mortality in persons with chronic kidney disease stage 3: A prospective cohort study.
    PLoS Med. 2020;17:e1003163.
    PubMed     Abstract available


  6. MAJOR RW, Shepherd D, Medcalf JF, Xu G, et al
    Correction: The Kidney Failure Risk Equation for prediction of end stage renal disease in UK primary care: An external validation and clinical impact projection cohort study.
    PLoS Med. 2020;17:e1003313.
    PubMed     Abstract available


    February 2020
  7. FENTON A, Chinnadurai R, Gullapudi L, Kampanis P, et al
    Association between non-malignant monoclonal gammopathy and adverse outcomes in chronic kidney disease: A cohort study.
    PLoS Med. 2020;17:e1003050.
    PubMed     Abstract available


    November 2019
  8. MAJOR RW, Shepherd D, Medcalf JF, Xu G, et al
    The Kidney Failure Risk Equation for prediction of end stage renal disease in UK primary care: An external validation and clinical impact projection cohort study.
    PLoS Med. 2019;16:e1002955.
    PubMed     Abstract available


    October 2019
  9. KHASHAN AS, Evans M, Kublickas M, McCarthy FP, et al
    Correction: Preeclampsia and risk of end stage kidney disease: A Swedish nationwide cohort study.
    PLoS Med. 2019;16:e1002977.
    PubMed     Abstract available


    July 2019
  10. KHASHAN AS, Evans M, Kublickas M, McCarthy FP, et al
    Preeclampsia and risk of end stage kidney disease: A Swedish nationwide cohort study.
    PLoS Med. 2019;16:e1002875.
    PubMed     Abstract available


    April 2019
  11. PERICO N, Ruggenenti P, Perna A, Caroli A, et al
    Octreotide-LAR in later-stage autosomal dominant polycystic kidney disease (ALADIN 2): A randomized, double-blind, placebo-controlled, multicenter trial.
    PLoS Med. 2019;16:e1002777.
    PubMed     Abstract available


    January 2019
  12. JORDAN DM, Choi HK, Verbanck M, Topless R, et al
    No causal effects of serum urate levels on the risk of chronic kidney disease: A Mendelian randomization study.
    PLoS Med. 2019;16:e1002725.
    PubMed     Abstract available


    March 2018
  13. LIN E, Chertow GM, Yan B, Malcolm E, et al
    Cost-effectiveness of multidisciplinary care in mild to moderate chronic kidney disease in the United States: A modeling study.
    PLoS Med. 2018;15:e1002532.
    PubMed     Abstract available


  14. FLUCK RJ, Taal MW
    What is the value of multidisciplinary care for chronic kidney disease?
    PLoS Med. 2018;15:e1002533.
    PubMed     Abstract available


    November 2017
  15. BOYD MA, Mocroft A, Ryom L, Monforte AD, et al
    Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study.
    PLoS Med. 2017;14:e1002424.
    PubMed     Abstract available


    October 2017
  16. SHARDLOW A, McIntyre NJ, Fraser SDS, Roderick P, et al
    The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: A primary care cohort study.
    PLoS Med. 2017;14:e1002400.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: